Richard Lamour, MD
Foot and Ankle Surgery · Olympia, WANPI 1164695813
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $61,576 of the $86,876 with a category attached, or 70.9%. Arthrex accounts for 76.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $30,486 and has fallen 79.8% since, to $6,167 in 2025. Among foot and ankle surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $827.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$67K
- Paragon 28, Inc.$11K
- Ossdsign USA Incorporated$6K
- Steelhead Surgical Inc$1K
- Stryker$1K
- Summit Surgical Corp.$750
- plus $87 from 5 others
What the payments were for
- Consulting fees$18,45621%
- Speaking & faculty fees$61,57671%
- Travel & lodging$5,0716%
- Food & beverage$1,7582%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 71 | $66,645 |
| Paragon 28, Inc. | 11 | $10,827 |
| Ossdsign USA Incorporated | 2 | $6,057 |
| Steelhead Surgical Inc | 2 | $1,364 |
| Stryker(2 entities) | 13 | $1,144 |
| Summit Surgical Corp. | 1 | $750 |
| Invictus Surgical Incorporated | 1 | $19 |
| Gemini Mountain Medical, LLC | 1 | $18 |
| Merck | 1 | $17 |
| Medline Industries LP | 1 | $17 |
| Fusion Orthopedics USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$86,876 in reported general payments places this provider in the 95th percentile of 203 foot and ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 82 | $985 |
| Oxycodone Hcl | 113 | $650 |
| Gabapentin | 23 | $225 |
| Ibuprofen | 69 | $213 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $97 |
| Hydromorphone Hcl | 11 | $67 |
| Tramadol Hcl | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Olympia
- Casey BowlesOlympia$11K
- Timothy DumontierOlympia$9K
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.